This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Beckman Research Institute, City of Hope. Active years: 2008-2013.
Location History:
- Arcadia, CA (US) (2008)
- Chicago, IL (US) (2013)
Company Filing History:
Years Active: 2008-2013
Title: Innovations by Tibor A. Rauch in Cancer Diagnostics
Introduction
Tibor A. Rauch is an accomplished inventor based in Chicago, IL, known for his significant contributions to the field of cancer diagnostics. With a focus on DNA methylation biomarkers, his work has the potential to revolutionize the way lung cancer is diagnosed and treated. He holds 2 patents that showcase his innovative approach to medical research.
Latest Patents
Rauch's latest patents include groundbreaking inventions that address critical challenges in cancer detection. The first patent, titled "DNA methylation biomarkers for lung cancer," relates to the identification of novel DNA biomarkers and the use of aberrant methylation patterns to diagnose lung cancers, such as squamous cell carcinomas and adenocarcinomas. The second patent, "Method for detecting methylated CpG islands," introduces a new assay termed the methylated-CpG island recovery assay (MIRA). This method enhances the detection of genomic methylated CpG islands through a series of precise steps involving genomic DNA fragments and specific binding proteins.
Career Highlights
Rauch is currently associated with City of Hope, a prominent research institution dedicated to advancing cancer treatment and care. His work at City of Hope has positioned him at the forefront of cancer research, where he continues to explore innovative solutions for early detection and diagnosis.
Collaborations
Throughout his career, Rauch has collaborated with esteemed colleagues, including Gerd P. Pfeifer and Xiwei Wu. These partnerships have fostered a collaborative environment that enhances the research and development of new diagnostic methods.
Conclusion
Tibor A. Rauch's contributions to cancer diagnostics through his innovative patents highlight the importance of research in improving patient outcomes. His work exemplifies the potential of scientific advancements in the fight against cancer.